The utility of novel urinary biomarker and traditional urinary biomarker in evaluating lupus disease activity.
<p><b>(A)</b> The difference between the levels of uMCP-1 in ALN and NALN. <b>(B)</b> The difference between the levels of uVCAM-1 in ALN and NALN. <b>(C)</b> The difference between the levels of u-β2MG in ALN and NALN. <b>(D)</b> The difference...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!